Timolol Maleate Sterile Ophthalmic Solution, USP 0.5%, 10mL, (NDC 16571-141-10). The products ...

FDA Drug Recall #D-1073-2014 — Class III — September 9, 2013

Recall Summary

Recall Number D-1073-2014
Classification Class III — Low risk
Date Initiated September 9, 2013
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm PACK Pharmaceuticals, LLC
Location Buffalo Grove, IL
Product Type Drugs
Quantity 2,022 bottles

Product Description

Timolol Maleate Sterile Ophthalmic Solution, USP 0.5%, 10mL, (NDC 16571-141-10). The products are packaged in Low Density Polyethylene (LDPE) Blow Fill Seal containers equipped with a dropper tip. The filled bottles are individually packaged into fiberboard cartons.

Reason for Recall

Defective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients along with the preservative, on the exterior of the bottles.

Distribution Pattern

Nationwide and Puerto Rico.

Lot / Code Information

Lot #:NDW3071,NDW3072. Exp.06/15

Other Recalls from PACK Pharmaceuticals, LLC

Recall # Classification Product Date
D-1069-2014 Class III Ofloxacin Ophthalmic Solution, USP 0.3%, 10mL, ... Sep 9, 2013
D-1072-2014 Class III Timolol Maleate Sterile Ophthalmic Solution, US... Sep 9, 2013
D-1068-2014 Class III Ofloxacin Ophthalmic Solution, USP 0.3%, 5mL, (... Sep 9, 2013
D-1071-2014 Class III Timolol Maleate Sterile Ophthalmic Solution, US... Sep 9, 2013
D-1070-2014 Class III Timolol Maleate Sterile Ophthalmic Solution, US... Sep 9, 2013

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.